Abstract
Bedaquiline (BDQ), approved by Food and Drug Administration (FDA) in 2012 as the first anti-tuberculosis-specific drug in the last 40 years, is viewed as one of the world’s most promising treatments for tuberculosis (TB). Due to the stereoselective construction of the Csp3—Csp3 bond with vicinal stereocenters of BDQ and its analogues being an unsolved challenge, there have not been any reports concerning its asymmetric synthesis for the current industrial production process until now. Herein, we have successfully developed a cooperative bimetallic system for the asymmetric synthesis of BDQ under the guidance of density functional theory (DFT) computations. Based on the optimized conditions, BDQ could be synthesized with excellent enantioselectivity (>99% ee) and diastereoselectivity (16:1 dr). A 5-g scale reaction was also conducted with comparably excellent results, showing its potential for industrial application.
Similar content being viewed by others
References
Lu P, Lill H, Bald D. Biochim Biophys Acta, 2014, 1837: 1208–1218
Smith Ii TC, Aldridge BB. Science, 2019, 364: 1234–1235
World Health Organization. Global Tuberculosis Report 2020. Vol. 148. World Health Organization, 2020
Abdool Karim Q, Abdool Karim SS. Science, 2020, 369: 366–368
De Rycker M, Baragaña B, Duce SL, Gilbert IH. Nature, 2018, 559: 498–506
Gygli SM, Loiseau C, Jugheli L, Adamia N, Trauner A, Reinhard M, Ross A, Borrell S, Aspindzelashvili R, Maghradze N, Reither K, Beisel C, Tukvadze N, Avaliani Z, Gagneux S. Nat Med, 2021, 27: 1171–1177
Andries K, Verhasselt P, Guillemont J, Gohlmann HWH, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V. Science, 2005, 307: 223–227
Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, Page-Shipp L, Pistorius C, Krause R, Bogoshi M, Churchyard G, Venter A, Allen J, Palomino JC, De Marez T, van Heeswijk RPG, Lounis N, Meyvisch P, Verbeeck J, Parys W, de Beule K, Andries K, McNeeley DF. N Engl J Med, 2009, 360: 2397–2405
Jones D. Nat Rev Drug Discov, 2013, 12: 175–176
Sutherland HS, Tong AST, Choi PJ, Blaser A, Franzblau SG, Cooper CB, Upton AM, Lotlikar M, Denny WA, Palmer BD. Bioorg Med Chem, 2020, 28: 115213–115225
Yao R, Wang B, Fu L, Li L, You K, Li YG, Lu Y. Microbiology Spectrum, 2022, 10: e02477-21
http://www.tballiance.org/portfolio/compound/tbaj-587-diarylquinoline, accessed 24th August 2019
http://www.tballiance.org/portfolio/compound/tbaj-876-diarylquinoline, accessed 24th August 2019
Kalia D, Kumar KSA, Meena G, Sethi KP, Sharma R, Trivedi P, Khan SR, Verma AS, Singh S, Sharma S, Roy KK, Kant R, Krishnan MY, Singh BN, Sinha S, Chaturvedi V, Saxena AK, Dikshit DK. MedChemComm, 2015, 6: 1554–1563
Choi PJ, Sutherland HS, Tong AST, Blaser A, Franzblau SG, Cooper CB, Lotlikar MU, Upton AM, Guillemont J, Motte M, Queguiner L, Andries K, van den Broeck W, Denny WA, Palmer BD. Bioorg Med Chem Lett, 2017, 27: 5190–5196
Vjecha MJ, Tiberi S, Zumla A. Nat Rev Drug Discov, 2018, 17: 607–608
Sutherland HS, Tong AST, Choi PJ, Conole D, Blaser A, Franzblau SG, Cooper CB, Upton AM, Lotlikar MU, Denny WA, Palmer BD. Bioorg Med Chem, 2018, 26: 1797–1809
Sarathy JP, Ragunathan P, Shin J, Cooper CB, Upton AM, Grüber G, Dick T. Antimicrob Agents Chemother, 2019, 63: e01191–19
Calvert MB, Furkert DP, Cooper CB, Brimble MA. Bioorg Med Chem Lett, 2020, 30: 127172–127181
Choi PJ, Conole D, Sutherland HS, Blaser A, Tong AST, Cooper CB, Upton AM, Palmer BD, Denny WA. Molecules, 2020, 25: 1423–1456
For reviews: (a) Christoffers J, Baro A. Quaternary Stereocentres: Challenges and Solutions for Organic Synthesis. Weinheim: Wiley-VCH, 2005
Beletskaya IP, Nájera C, Yus M. Chem Rev, 2018, 118: 5080–5200
Tomita D, Yamatsugu K, Kanai M, Shibasaki M. J Am Chem Soc, 2009, 131: 6946–6948
Quasdorf KW, Overman LE. Nature, 2014, 516: 181–191
Yang Y, Perry IB, Lu G, Liu P, Buchwald SL. Science, 2016, 353: 144–150
Andries K, Gestel JV. Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases. European Patant, 04102402.7, 2004-05-28
Saga Y, Motoki R, Makino S, Shimizu Y, Kanai M, Shibasaki M. J Am Chem Soc, 2010, 132: 7905–7907
Chandrasekhar S, Babu GSK, Mohapatra DK. Eur J Org Chem, 2011, 2011: 2057–2061
Lubanyana H, Arvidsson PI, Govender T, Kruger HG, Naicker T. ACS Omega, 2020, 5: 3607–3611
For selected patents: (a) Gestel JV, Guillemont J, Venet M, Decrane L, Vernier D, Odds F, Csoka I, Andries K. Quinoline derivatives and their use as mycobacterial inhibitors. European Patent, 1527050B1, 2003-07-18
Porstmann F, Horns S, Bader T. Process for preparing (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamine)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol. European Patent, 05104482.4, 2005-05-25
Hegyi JF, Aelterman W, Lang Y, Stokbroekx SCM, Leys C, van Remoortere PJM, Faure A. Fumarate salt of (alpha S, Beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol. European Patent, 06125443.9, 2006-12-05
Zhao X, Huang Y, Zheng Z, Lin Y, Chen Z. Chiral inducer for synthesizing (1S,2R)-bedaquiline. China Patent, 106866525.A, 2017-03-24
Li S, Zhong W, Li P, Xiao J, Zheng Z, Xie Y, Zhao G, Wang X, Wang L, Li X, Zhou X. Aromatic butan-2-ol compounds, preparation methods and uses thereof. China Patent, 102249935.A, 2010-05-17
Guillemont J, Meyer C, Koul A, Andries K. Diastereomers, enantiomers and bioactivity. TMC207: A new candidate for the treatment of tuberculosis. In: Carreira, EM, Yamamoto H, Eds. Comprehensive Chirality. Volume 1: Biological Significance-pharmacology, Pharmaceutical Agrochemical. Amsterdam: Elsevier, 2012. 54–69
Li J, Li Y, Bing S, Wu X, Zhou A, Huang L, Jin R, Wang J, Jiang M, Wang L. Preparation method for bedaquiline. China Patent, 105085396.A, 2014-05-07
For selected papers: (a) Krautwald S, Sarlah D, Schafroth MA, Carreira EM. Science, 2013, 340: 1065–1068
Krautwald S, Schafroth MA, Sarlah D, Carreira EM. J Am Chem Soc, 2014, 136: 3020–3023
Naesborg L, Halskov KS, Tur F, Mønsted SMN, Jørgensen KA. Angew Chem Int Ed, 2015, 54: 10193–10197
Sandmeier T, Krautwald S, Zipfel HF, Carreira EM. Angew Chem Int Ed, 2015, 54: 14363–14367
Jiang X, Beiger JJ, Hartwig JF. J Am Chem Soc, 2017, 139: 87–90
Cruz FA, Dong VM. J Am Chem Soc, 2017, 139: 1029–1032
Kassem S, Lee ATL, Leigh DA, Marcos V, Palmer LI, Pisano S. Nature, 2017, 549: 374–378
Wang H, Zhang R, Zhang Q, Zi W. J Am Chem Soc, 2021, 143: 10948–10962
Zhang MM, Wang YN, Wang BC, Chen XW, Lu LQ, Xiao WJ. Nat Commun, 2019, 10: 2716–2742
Singha S, Serrano E, Mondal S, Daniliuc CG, Glorius F. Nat Catal, 2020, 3: 48–54
Zhang J, Gao YS, Gu BM, Yang WL, Tian BX, Deng WP. ACS Catal, 2021, 11: 3810–3821
Zhu DX, Liu JG, Xu MH. J Am Chem Soc, 2021, 143: 8583–8589
Zhang Q, Zhu M, Zi W. Chem, 2022, 8: 1–13
Zhu M, Wang P, Zhang Q, Tang W, Zi W. Angew Chem Int Ed, 2022, 61: e202207621
For selected papers: (a) Huo X, He R, Zhang X, Zhang W. J Am Chem Soc, 2016, 138: 11093–11096
He R, Liu P, Huo X, Zhang W. Org Lett, 2017, 19: 5513–5516
Huo X, Zhang J, Fu J, He R, Zhang W. J Am Chem Soc, 2018, 140: 2080–2084
He R, Huo X, Zhao L, Wang F, Jiang L, Liao J, Zhang W. J Am Chem Soc, 2020, 142: 8097–8103
Huo X, Zhao L, Luo Y, Wu Y, Sun Y, Li G, Gridneva T, Zhang J, Ye Y, Zhang W. CCS Chem, 2022, 4: 1720–1731
Zhang J, Huo X, Xiao J, Zhao L, Ma S, Zhang W. J Am Chem Soc, 2021, 143: 12622–12632
Peng Y, Huo X, Luo Y, Wu L, Zhang W. Angew Chem Int Ed, 2021, 60: 24941–24949
For selected papers: (a) Jiang X, Boehm P, Hartwig JF. J Am Chem Soc, 2018, 140: 1239–1242
Wei L, Zhu Q, Xu SM, Chang X, Wang CJ. J Am Chem Soc, 2018, 140: 1508–1513
Xu SM, Wei L, Shen C, Xiao L, Tao HY, Wang CJ. Nat Commun, 2019, 10: 5553–5563
He ZT, Jiang X, Hartwig JF. J Am Chem Soc, 2019, 141: 13066–13073
Zhang Q, Yu H, Shen L, Tang T, Dong D, Chai W, Zi W. J Am Chem Soc, 2019, 141: 14554–14559
Zhu M, Zhang Q, Zi W. Angew Chem Int Ed, 2021, 60: 6545–6552
Yang SQ, Wang YF, Zhao WC, Lin GQ, He ZT. J Am Chem Soc, 2021, 143: 7285–7291
Masson-Makdissi J, Prieto L, Abel-Snape X, Lautens M. Angew Chem Int Ed, 2021, 60: 16932–16936
Xiao L, Wei L, Wang CJ. Angew Chem Int Ed, 2021, 60: 24930–24940
Wei L, Wang C. Chin J Chem, 2021, 39: 15–24
Chai W, Guo B, Zhang Q, Zi W. Chem Catal, 2022, 2: 1428–1439
Xu Y, Wang H, Yang Z, Zhou Y, Liu Y, Feng X. Chem, 2022, 8: 2011–2022
Huo X, Li G, Wang X, Zhang W. Angew Chem Int Ed, 2022, e20221008 (in press)
Wang H, Xu Y, Zhang F, Liu Y, Feng X. Angew Chem Int Ed, 2022, 61: 202115715
Chang X, Cheng X, Liu XT, Fu C, Wang WY, Wang CJ. Angew Chem Int Ed, 2022, 61: 202206517
Wang W, Zhang F, Liu Y, Feng X. Angew Chem Int Ed, 2022, 61: e202208837
Kim B, Kim Y, Lee SY. J Am Chem Soc, 2021, 143: 73–79
Huo X, He R, Fu J, Zhang J, Yang G, Zhang W. J Am Chem Soc, 2017, 139: 9819–9822
Xia J, Hirai T, Katayama S, Nagae H, Zhang W, Mashima K. ACS Catal, 2021, 11: 6643–6655
Peng Y, Han C, Luo Y, Li G, Huo X, Zhang W. Angew Chem Int Ed, 2022, 61: e202203448
Just before the submission of this manuscript, a paper about the diastereoselective synthesis of BDQ for the current process was published in which the dr was increased to 2.4:1: Mear S, Lucas T, Ahlqvist G, Robey J, Dietz JP, Khairnar P, Maity S, Williams C, Snead D, Nelson R, Opatz T, Jamison T. Chem Eur J, 2022, e202201311 (in press)
Only one example about the enantio- and diastereoselective addition of secondary carbanions to ketones was found: Ko YK, Im C, Do J, Park YS. Eur J Org Chem, 2014, 2014(16): 3460–3467
Wallenhauer S, Seppelt K. Inorg Chem, 1995, 34: 116–119
De Vries TS, Goswami A, Liou LR, Gruver JM, Jayne E, Collum DB. J Am Chem Soc, 2009, 131: 13142–13154
Armstrong DR, García-Alvarez P, Kennedy AR, Mulvey RE, Parkinson JA. Angew Chem Int Ed, 2010, 49: 3185–3188
Reich HJ. Chem Rev, 2013, 113: 7130–7178
Reyes-Rodríguez GJ, Algera RF, Collum DB. J Am Chem Soc, 2017, 139: 1233–1244
Fokin AA, Chernish LV, Gunchenko PA, Tikhonchuk EY, Hausmann H, Serafin M, Dahl JEP, Carlson RMK, Schreiner PR. J Am Chem Soc, 2012, 134: 13641–13650
Rösel S, Balestrieri C, Schreiner PR. Chem Sci, 2017, 8: 405–410
Petit S, Coquerel G, Meyer C, Guillemont J. J Mol Struct, 2007, 837: 252–256
Ishigaki Y, Shimajiri T, Takeda T, Katoono R, Suzuki T. Chem, 2018, 4: 795–806
Pratt LM, Khan IM. J Mol Struct, 1996, 367: 33–40
Armstrong DR, Davies RP, Raithby PR, Snaith R, Wheatley, AEH. New J Chem, 1999, 23: 499–507
Al-Masri HT, Sieler J, Hey-Hawkins E. Appl Organomet Chem, 2003, 17: 63–67
Veličković SR, Koteski VJ, Belošević Čavor JN, Djordjević VR, Cvetićanin JM, Djustebek JB, Veljković MV, Nešković OM. Chem PhysLett, 2007, 448: 151–155
Neufeld R, Teuteberg TL, Herbst-Irmer R, Mata RA, Stalke D. J Am Chem Soc, 2016, 138: 4796–4806
Lu G, Liu RY, Yang Y, Fang C, Lambrecht DS, Buchwald SL, Liu P. J Am Chem Soc, 2017, 139: 16548–16555
Xi Y, Su B, Qi X, Pedram S, Liu P, Hartwig JF. J Am Chem Soc, 2020, 142: 18213–18222
Chen J, Zhang Z, Li B, Li F, Wang Y, Zhao M, Gridnev ID, Imamoto T, Zhang W. Nat Commun, 2018, 9: 5000–5009
Li B, Chen J, Zhang Z, Gridnev ID, Zhang W. Angew Chem Int Ed, 2019, 58: 7329–7334
Hu Y, Chen J, Li B, Zhang Z, Gridnev ID, Zhang W. Angew Chem Int Ed, 2020, 59: 5371–5375
Zhang J, Chen T, Wang Y, Zhou F, Zhang Z, Gridnev ID, Zhang W. Nat Sci, 2021, 1: e10021
Li B, Chen J, Liu D, Gridnev ID, Zhang W. Nat Chem, 2022, 14: 920–927
Changotra A, Bhaskararao B, Hadad CM, Sunoj RB. J Am Chem Soc, 2020, 142: 9612–9624
Xu H, Li B, Liu Z, Dang Y. ACS Catal, 2021, 11: 9008–9021
Li B, Xu H, Dang Y, Houk KN. J Am Chem Soc, 2022, 144: 1971–1985
Bader RFW. Acc Chem Res, 1985, 18: 9–15
Lu T, Chen F. J Comput Chem, 2012, 33: 580–592
Emamian S, Lu T, Kruse H, Emamian H. J Comput Chem, 2019, 40: 2868–2881
Acknowledgements
This work was supported by the Bill and Melinda Gates Foundation (INV-008413), the National Natural Science Foundation of China (21831005), and Shanghai Jiao Tong University. We appreciate Dr. George Wang, Dr. Christopher Cooper, Dr. Rajneesh Taneja, Dr. John Dillon, Dr. Trevor Laird and Dr. Jordi Robinson for their helpful discussions. We thank Dr. Niya Bowers (BMGF) for the project management and the Instrumental Analysis Center of SJTU for characterization.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest The authors declare no conflict of interest.
Additional information
Dedicated to Professor Guoqiang Lin on the occasion of his 80th birthday.
Supporting information The supporting information is available online at http://chem.scichina.com and http://link.springer.com/journal/11426. The supporting materials are published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content remains entirely with the authors.
Rights and permissions
About this article
Cite this article
Gao, F., Li, J., Ahmad, T. et al. Asymmetric synthesis of bedaquiline based on bimetallic activation and non-covalent interaction promotion strategies. Sci. China Chem. 65, 1968–1977 (2022). https://doi.org/10.1007/s11426-022-1387-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-022-1387-7